All patients “above the water” have the characteristic damage of the small intestinal lining (flattening of the villi) with an elevation of their blood antibodies against tissue transglutaminase (“tTG”), and at least one of the genetic markers, HLA-DQ2 or DQ8 known to be necessary in order for celiac disease to exist. The gene discussed is TGM2; the disease is celiac disease.